BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 17675058)

  • 1. Multiparametric risk stratification in patients with mild to moderate chronic heart failure.
    Scardovi AB; De Maria R; Coletta C; Aspromonte N; Perna S; Cacciatore G; Parolini M; Ricci R; Ceci V
    J Card Fail; 2007 Aug; 13(6):445-51. PubMed ID: 17675058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between B-type natriuretic peptide levels and ventilatory response during cardiopulmonary exercise test in patients with chronic heart failure.
    Scardovi AB; Coletta C; Aspromonte N; Perna S; Infusino T; Carunchio A; D'Errigo P; Seccareccia F; De Maria R; Greggi M; Di Giacomo T; Ricci R; Ceci V
    Minerva Cardioangiol; 2005 Aug; 53(4):313-20. PubMed ID: 16177675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain natriuretic peptide is a reliable indicator of ventilatory abnormalities during cardiopulmonary exercise test in heart failure patients.
    Scardovi AB; De Maria R; Colettat C; Aspromonte N; Perna S; Infusino T; D'Errigo P; Rosato S; Greggi M; Di Giacomo T; Riccio R; Cec V
    Med Sci Monit; 2006 May; 12(5):CR191-5. PubMed ID: 16641874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
    Pascual-Figal DA; Peñafiel P; Nicolas F; de la Morena G; Ansaldo P; Redondo B; Sánchez Mas J; Valdés M
    Rev Esp Cardiol; 2008 Mar; 61(3):260-8. PubMed ID: 18361899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
    Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
    Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure.
    Passino C; Pingitore A; Landi P; Fontana M; Zyw L; Clerico A; Emdin M; Iervasi G
    J Card Fail; 2009 Feb; 15(1):35-40. PubMed ID: 19181292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of prognosis in patients with stable mild to moderate heart failure.
    Bettencourt P; Ferreira A; Dias P; Pimenta J; Friões F; Martins L; Cerqueira-Gomes M
    J Card Fail; 2000 Dec; 6(4):306-13. PubMed ID: 11145755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.
    Valle R; Aspromonte N; Feola M; Milli M; Canali C; Giovinazzo P; Carbonieri E; Ceci V; Cerisano S; Barro S; Milani L
    J Card Fail; 2005 Sep; 11(7):498-503. PubMed ID: 16198244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure.
    de Groote P; Dagorn J; Soudan B; Lamblin N; McFadden E; Bauters C
    J Am Coll Cardiol; 2004 May; 43(9):1584-9. PubMed ID: 15120815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide levels in obese patients with advanced heart failure.
    Horwich TB; Hamilton MA; Fonarow GC
    J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?
    de Groote P; Soudan B; Lamblin N; Rouaix-Emery N; Mc Fadden E; Meurice T; Mouquet F; Bauters C
    Am Heart J; 2004 Aug; 148(2):349-55. PubMed ID: 15309008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diastolic function and BNP changes during exercise predict oxygen consumption in chronic heart failure patients.
    Ciampi Q; Borzillo G; Barbato E; Petruzziello B; Betocchi S; Villari B
    Scand Cardiovasc J; 2009 Feb; 43(1):17-23. PubMed ID: 18609042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis.
    Agostoni P; Corrà U; Cattadori G; Veglia F; La Gioia R; Scardovi AB; Emdin M; Metra M; Sinagra G; Limongelli G; Raimondo R; Re F; Guazzi M; Belardinelli R; Parati G; Magrì D; Fiorentini C; Mezzani A; Salvioni E; Scrutinio D; Ricci R; Bettari L; Di Lenarda A; Pastormerlo LE; Pacileo G; Vaninetti R; Apostolo A; Iorio A; Paolillo S; Palermo P; Contini M; Confalonieri M; Giannuzzi P; Passantino A; Cas LD; Piepoli MF; Passino C;
    Int J Cardiol; 2013 Sep; 167(6):2710-8. PubMed ID: 22795401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.